文献速递淋巴瘤

经典型霍奇金淋巴瘤与原发性纵隔大B细胞淋巴瘤的复合型及序贯型淋巴瘤:25例临床病理系列

Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases.
PubMed 文献 · Br J Haematol · 2020-02-06

该回顾性研究经中心病理复核纳入10例复合型和15例序贯型经典型霍奇金淋巴瘤(CHL)与原发性纵隔B细胞淋巴瘤(PMBCL)病例,描述其病理与临床特征。复合型病例诊断时70%呈播散性结外病变,中位随访34个月全部存活并完全缓解;序贯型中早期病例预后差,晚期病例可有效挽救。

要点

  • 复合型CHL/PMBCL诊断时70%为播散性结外病变,中位随访34个月全部完全缓解存活。
  • 序贯型中12例首发为CHL、3例首发为PMBCL,早期序贯(1年内)预后差。
  • 晚期序贯型(长期完全缓解后复发)可被有效挽救。

核心结论

  • 复合型和序贯型CHL/PMBCL罕见,复合型病例经治疗后中位随访34个月全部存活并完全缓解。
  • 早期序贯型淋巴瘤预后尤其差,中位总生存短于一年,而晚期序贯型可有效挽救。

研究设计与样本

  • 回顾性分析经中心病理复核纳入的10例复合型和15例序贯型CHL/PMBCL病例的病理与临床特征。

主要发现

  • 复合型淋巴瘤诊断时70%呈现播散性和结外病变。
  • 15例序贯型中12例首次发生为CHL,3例为PMBCL。
  • 序贯型按临床演变分为早期(一年内诊断第二淋巴瘤)和晚期(长期完全缓解后发生第二淋巴瘤)。
  • 全部复合型病例在中位随访34个月时存活并处于完全缓解。
  • 早期序贯型预后特别差,中位总生存短于一年;晚期病例可有效挽救。

临床怎么用

  • 对CHL或PMBCL患者需警惕复合型或序贯型淋巴瘤可能,诊断时注意结外播散病变。
  • 序贯型淋巴瘤发生后应区分早期与晚期,早期病例需更积极干预。

局限性

  • 回顾性分析样本量小(共25例),结果需更大系列验证。
  • 需进一步分子研究阐述这些罕见疾病的生物学,可能代表灰区淋巴瘤中肿瘤细胞可塑性的极端表现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Composite and sequential lymphomas involving both classical Hodgkin lymphoma (CHL) and primary mediastinal B-cell lymphoma (PMBCL) are rare phenomena. Beyond the relevant biological interest raised by these cases, treatments and outcome data are poorly covered in the recent literature. This retrospective analysis describes the pathological and clinical characteristics of 10 composite and 15 sequential cases included after a central pathological review. At diagnosis, 70% of the composite lymphomas presented a disseminated and extranodal disease. Among the 15 sequential lymphomas, 12 were CHL at first occurrence and three were PMBCL. Based on their clinical evolution, these sequential lymphomas could be divided into early (i.e., diagnosis of second lymphoma within a year) and late [(i.e., a second lymphoma occurrence occurring after a long period of complete remission]). All composite cases were alive in complete remission after a median follow-up of 34 months. If the early sequential lymphoma presented a particularly poor outcome with a median overall survival shorter than one year, the late cases were efficiently salvaged. Further molecular studies are needed to describe the underlying biology of these rare diseases, possibly representing the extreme of tumour cell plasticity found in grey-zone lymphoma.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Aussedat G, Traverse-Glehen A, Stamatoullas A, et al. Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases. Br J Haematol. 2020. PMID: 32030731. doi:10.1111/bjh.16331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。